Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

AiCuris GmbH & Co. KG - Product Pipeline Review - 2015

Published: Feb-2015 | Format: PDF | Global Markets Direct | Number of pages: 36 | Code: MRS - 7033

 

Global Markets Direct’s, ‘AiCuris GmbH & Co. KG Product Pipeline Review 2015’, provides an overview of the AiCuris GmbH & Co. KG’s pharmaceutical research and development focus.

 

This report provides comprehensive information on the current therapeutic developmental pipeline of AiCuris GmbH & Co. KG’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

 

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

 

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

 

Scope

 

The report provides brief overview of AiCuris GmbH & Co. KG including business description, key information and facts, and its locations and subsidiaries
The report reviews current pipeline of AiCuris GmbH & Co. KG’s human therapeutic division and enlists all their major and minor projects
The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones 
Special feature on out-licensed and partnered product portfolio
The report summarizes all the dormant and discontinued pipeline projects
Latest company statement 
Latest news and deals relating to the AiCuris GmbH & Co. KG’s pipeline products

 

Reasons to buy

 

Evaluate AiCuris GmbH & Co. KG’s strategic position with total access to detailed information on its product pipeline
Assess the growth potential of AiCuris GmbH & Co. KG in its therapy areas of focus
Identify new drug targets and therapeutic classes in the AiCuris GmbH & Co. KG’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
Develop strategic initiatives by understanding the focus areas of AiCuris GmbH & Co. KG and exploit collaboration and partnership opportunities
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Plan mergers and acquisitions effectively by identifying the most promising pipeline of AiCuris GmbH & Co. KG
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Explore the dormant and discontinued projects of AiCuris GmbH & Co. KG and identify potential opportunities in those areas
Avoid Intellectual Property Rights related issues

 

Table of Contents
 

 

Table of Contents 2
List of Tables 4
List of Figures 4
AiCuris GmbH & Co. KG Snapshot 5
AiCuris GmbH & Co. KG Overview 5
Key Information 5
Key Facts 5
AiCuris GmbH & Co. KG – Research and Development Overview 6
Key Therapeutic Areas 6
AiCuris GmbH & Co. KG – Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products – Monotherapy 10
Pipeline Products – Out-Licensed Products 11
Out-Licensed Products/Combination Treatment Modalities 12
AiCuris GmbH & Co. KG – Pipeline Products Glance 13
AiCuris GmbH & Co. KG – Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Phase I Products/Combination Treatment Modalities 14
AiCuris GmbH & Co. KG – Early Stage Pipeline Products 15
Preclinical Products/Combination Treatment Modalities 15
Discovery Products/Combination Treatment Modalities 16
AiCuris GmbH & Co. KG – Drug Profiles 17
pritelivir 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
AIC-284 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
AIC-649 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
AIC-277 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
AIC-499 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Small Molecule 1 for Gram-Negative Bacterial Infections 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Small Molecule 2 for Gram-Negative Bacterial Infections 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Small Molecule for Bacteral Infections 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Small Molecule for Gram-Positive Bacterial Infections 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Small Molecule for Infectious Disease 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Small Molecule for Viral Infections 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
AiCuris GmbH & Co. KG – Pipeline Analysis 28
AiCuris GmbH & Co. KG – Pipeline Products by Target 28
AiCuris GmbH & Co. KG – Pipeline Products by Route of Administration 29
AiCuris GmbH & Co. KG – Pipeline Products by Molecule Type 30
AiCuris GmbH & Co. KG – Pipeline Products by Mechanism of Action 31
AiCuris GmbH & Co. KG – Recent Pipeline Updates 32
AiCuris GmbH & Co. KG – Dormant Projects 33
AiCuris GmbH & Co. KG – Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34

 

Appendix 35
Methodology 35
Coverage 35
Secondary Research 35
Primary Research 35
Expert Panel Validation 35
Contact Us 35
Disclaimer 36


List of Tables
 

AiCuris GmbH & Co. KG, Key Information 5
AiCuris GmbH & Co. KG, Key Facts 5
AiCuris GmbH & Co. KG – Pipeline by Indication, 2015 8
AiCuris GmbH & Co. KG – Pipeline by Stage of Development, 2015 9
AiCuris GmbH & Co. KG – Monotherapy Products in Pipeline, 2015 10
AiCuris GmbH & Co. KG – Out-Licensed Products in Pipeline, 2015 11
AiCuris GmbH & Co. KG – Out-Licensed Products/ Combination Treatment Modalities, 2015 12
AiCuris GmbH & Co. KG – Phase II, 2015 13
AiCuris GmbH & Co. KG – Phase I, 2015 14
AiCuris GmbH & Co. KG – Preclinical, 2015 15
AiCuris GmbH & Co. KG – Discovery, 2015 16
AiCuris GmbH & Co. KG – Pipeline by Target, 2015 28
AiCuris GmbH & Co. KG – Pipeline by Route of Administration, 2015 29
AiCuris GmbH & Co. KG – Pipeline by Molecule Type, 2015 30
AiCuris GmbH & Co. KG – Pipeline Products by Mechanism of Action, 2015 31
AiCuris GmbH & Co. KG – Recent Pipeline Updates, 2015 32
AiCuris GmbH & Co. KG – Dormant Developmental Projects,2015 33
AiCuris GmbH & Co. KG, Other Locations 34


 

List of Figures
 

AiCuris GmbH & Co. KG – Pipeline by Top 10 Indication, 2015 7
AiCuris GmbH & Co. KG – Pipeline by Stage of Development, 2015 9
AiCuris GmbH & Co. KG – Monotherapy Products in Pipeline, 2015 10
AiCuris GmbH & Co. KG – Out-Licensed Products in Pipeline, 2015 11
AiCuris GmbH & Co. KG – Pipeline by Top 10 Target, 2015 28
AiCuris GmbH & Co. KG – Pipeline by Top 10 Route of Administration, 2015 29
AiCuris GmbH & Co. KG – Pipeline by Top 10 Molecule Type, 2015 30
AiCuris GmbH & Co. KG – Pipeline Products by Top 10 Mechanism of Action, 2015 31

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode
Single User | $(USD)1500 View Pricing